Addolorata Maria Luce Coluccia

<i>In vitro</i> and <i>In vivo</i> Activity of SKI-606, a Novel Src-Abl Inhibitor, against Imatinib-Resistant Bcr-Abl+ Neoplastic Cells

Miriam Puttini, Addolorata Maria Luce Coluccia, Frank Boschelli et al. · Cancer Research · 2006 · 371 citations

Medicine, Oncology, Pharmacology +11

Bcr‐Abl stabilizes β‐catenin in chronic myeloid leukemia through its tyrosine phosphorylation

Addolorata Maria Luce Coluccia, Angelo Vacca, Mireia Duñach et al. · The EMBO Journal · 2007 · 215 citations · Full text

Medicine, Cancer Biology, Oncology +9

Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients

Lorena Passoni, Luca Longo, Paola Collini et al. · Cancer Research · 2009 · 170 citations · Full text

Medicine, Cancer Biology, Oncology +17

Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma

C. Scavelli, Beatrice Nico, Teresa Cirulli et al. · Oncogene · 2007 · 140 citations · Full text

Medicine, Hematology, Immunology +16

SKI-606 Decreases Growth and Motility of Colorectal Cancer Cells by Preventing pp60(c-Src)–Dependent Tyrosine Phosphorylation of β-Catenin and Its Nuclear Signaling

Addolorata Maria Luce Coluccia, Daniela Benati, Hafedh Dekhil et al. · Cancer Research · 2006 · 113 citations · Full text

Medicine, Molecular Biology, Oncology +17